# Study of NAV-240 in Healthy Volunteers

> **NCT06181786** · PHASE1 · COMPLETED · sponsor: **Navigator Medicines, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NAV-240
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06181786
- **Lead sponsor:** Navigator Medicines, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-22
- **Primary completion:** 2024-09-04
- **Final completion:** 2024-09-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06181786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06181786, "Study of NAV-240 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06181786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*